Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG Inhibition.

Li L, Okumu AA, Nolan S, English A, Vibhute S, Lu Y, Hervert-Thomas K, Seffernick JT, Azap L, Cole SL, Shinabarger D, Koeth LM, Lindert S, Yalowich JC, Wozniak DJ, Mitton-Fry MJ.

ACS Infect Dis. 2019 Jul 12;5(7):1115-1128. doi: 10.1021/acsinfecdis.8b00375. Epub 2019 May 9.

PMID:
31041863
2.

Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.

Koeth LM, Matuschek E, Kahlmeter G, Stone G.

Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1047-1053. doi: 10.1007/s10096-018-3215-9. Epub 2018 Mar 30.

PMID:
29603034
3.

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.

Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T, Hindler JA, Koeth L, Sei K; CLSI Methods Development and Standardization Working Group of the Subcommittee on Antimicrobial Susceptibility Testing.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01934-17. doi: 10.1128/JCM.01934-17. Print 2018 Apr. Review.

4.

Analysis of MIC and Disk Diffusion Testing Variables for Gepotidacin and Comparator Agents against Select Bacterial Pathogens.

Koeth LM, DiFranco-Fisher JM, Scangarella-Oman NE, Miller LA.

J Clin Microbiol. 2017 Jun;55(6):1767-1777. doi: 10.1128/JCM.02366-16. Epub 2017 Mar 22.

5.

Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.

Mortensen JE, DeBurger B, Powell EA, DiFranco-Fisher J, Koeth L, Weissman SJ.

J Glob Antimicrob Resist. 2016 Dec;7:141-144. doi: 10.1016/j.jgar.2016.08.012. Epub 2016 Oct 19.

PMID:
27835839
6.

Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.

Hastey CJ, Boyd H, Schuetz AN, Anderson K, Citron DM, Dzink-Fox J, Hackel M, Hecht DW, Jacobus NV, Jenkins SG, Karlsson M, Knapp CC, Koeth LM, Wexler H, Roe-Carpenter DE; From the Ad Hoc Working Group on Antimicrobial Susceptibility Testing of Anaerobic Bacteria of CLSI.

Anaerobe. 2016 Dec;42:27-30. doi: 10.1016/j.anaerobe.2016.07.003. Epub 2016 Jul 15.

7.

Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus.

Koeth LM, Apfalter P, Becker K, Gesu G, Martínez-Martínez L, Lahiri SD, Alm RA, Ambler J, Iaconis J.

Diagn Microbiol Infect Dis. 2016 Aug;85(4):452-8. doi: 10.1016/j.diagmicrobio.2016.05.003. Epub 2016 May 8.

PMID:
27233426
8.

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically.

Koeth LM, DiFranco-Fisher JM, McCurdy S.

J Vis Exp. 2015 Sep 9;(103). doi: 10.3791/53028.

9.

Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.

Koeth LM, Matuschek E, Kahlmeter G, Alm RA, Ambler JE.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1511-7. doi: 10.1007/s10096-014-2089-8. Epub 2014 Apr 18.

PMID:
24744220
10.

Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.

King ST, Usery JB, Holloway K, Koeth L, Cleveland KO, Gelfand MS.

J Antimicrob Chemother. 2011 Nov;66(11):2673-5. doi: 10.1093/jac/dkr343. Epub 2011 Aug 16. No abstract available.

PMID:
21846674
11.

Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates.

Koeth LM, DiFranco JM.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1261-4. doi: 10.1007/s10096-010-0996-x. Epub 2010 Jun 22.

PMID:
20567868
12.

Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus.

Friedrich L, Thorne G, Steenbergen JN, Anastasiou D, Koeth L.

Diagn Microbiol Infect Dis. 2009 Nov;65(3):306-11. doi: 10.1016/j.diagmicrobio.2009.07.012. Epub 2009 Sep 16.

PMID:
19762196
13.

Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.

Credito K, Lin G, Koeth L, Sturgess MA, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Feb;53(2):814-7. doi: 10.1128/AAC.01132-08. Epub 2008 Nov 17.

14.

Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent.

Sader HS, Koeth LM, Poupard JA, Jones RN.

Diagn Microbiol Infect Dis. 2008 Dec;62(4):460-3. doi: 10.1016/j.diagmicrobio.2008.08.020. Epub 2008 Nov 5.

PMID:
18990533
15.

Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines.

Ambler J, Rennie R, Poupard J, Koeth L, Stass H, Endermann R, Choudhri S.

Diagn Microbiol Infect Dis. 2008 May;61(1):49-57. doi: 10.1016/j.diagmicrobio.2008.01.013. Epub 2008 Mar 14.

PMID:
18342475
16.

Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.

Rennie RP, Koeth L, Jones RN, Fritsche TR, Knapp CC, Killian SB, Goldstein BP.

J Clin Microbiol. 2007 Oct;45(10):3151-4. Epub 2007 Aug 1.

17.

Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.

Julian K, Kosowska-Shick K, Whitener C, Roos M, Labischinski H, Rubio A, Parent L, Ednie L, Koeth L, Bogdanovich T, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Sep;51(9):3445-8. Epub 2007 Jul 9.

18.
19.

Evolving concepts of pharmaceutical company-sponsored surveillance studies.

Koeth LM, Miller LA.

Clin Infect Dis. 2005 Aug 15;41 Suppl 4:S279-82. Review.

PMID:
16032566
20.
21.

Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs.

Kosowska K, Jacobs MR, Bajaksouzian S, Koeth L, Appelbaum PC.

Antimicrob Agents Chemother. 2004 Oct;48(10):4020-2.

22.

Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.

Koeth LM, Good CE, Saunders KA, Jakielaszek C.

Int J Antimicrob Agents. 2004 Aug;24(2):144-9.

PMID:
15288313
23.

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.

Koeth LM, Good CE, Appelbaum PC, Goldstein EJ, Rodloff AC, Claros M, Dubreuil LJ.

J Antimicrob Chemother. 2004 Jun;53(6):1039-44. Epub 2004 May 5.

PMID:
15128729
24.

Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000.

Koeth LM, Felmingham D, Jacobs MR, Rossi F.

Int J Antimicrob Agents. 2004 Apr;23(4):356-61.

PMID:
15081084
25.

Comparison of daptomycin MIC results by DIN, NCCLS, SFM, and SRGA methods for 297 Gram-positive organisms.

Koeth LM, Leclercq R, Olsson-Liljequist B.

Int J Antimicrob Agents. 2004 Jan;23(1):17-24.

PMID:
14732309
26.

Use of appropriate breakpoints in antimicrobial surveillance studies.

Jacobs MR, Koeth LM, Appelbaum PC.

Clin Infect Dis. 2002 Dec 1;35(11):1446-8; author reply 1448-9. No abstract available.

PMID:
12439815
27.

Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae.

Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Lin G, Felmingham D, Dencer C, Koeth L, Singer ME, Good CE.

J Clin Microbiol. 2002 Sep;40(9):3269-76.

29.

Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.

Koeth LM, King A, Knight H, May J, Miller LA, Phillips I, Poupard JA.

J Antimicrob Chemother. 2000 Sep;46(3):369-76.

PMID:
10980162

Supplemental Content

Support Center